DISCOVER
CRO ALLIANCE
The power
of an international network
The CRO Alliance is an international network of CROs sharing the same technological platform for clinical trials: CleanWeb.
This Alliance enables:
- Perfect match with individual CRO partner current resources and services
- Significant competitive advantage on the CRO partner respective market(s)
- Set up of all clinical trial phases and complexity
- Access to TECH Alliance innovations
- Dedicated support of the CRO partner to boost business growth with a single point-of contact
- Provision of a DPO for all CRO Alliance members
- Global contacts database to increase business opportunities
A FULL SERVICE OFFER
A network of CROs to offer full services
in an international scale:
OUR COMMITMENTS
- Commitment to prioritise preparation of proposals for the CROs in the Alliance
- Detailed proposal matching of study-specific needs in up to 1 week
- Availability for demos, F2F meetings and teleconferences to support the CRO partner during its interactions with Sponsors, under CRO partner umbrella
- Willingness to evaluate eClinical tools upgrades matching CRO partners’ needs & processes
22 years of experience
All phases
Full Flexibility
Multiple user friendly tools and apps, combined or stand-alone, in interaction with externel data sources and systems or not
Very strong focus on Quality
Combined expertise in eClinical as CRO
Cost-effectiveness model
Collaborative ways of working
Built according to individual cro partner needs
Interested in becoming part of the CRO Alliance or just want to learn more?
A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT
64 +
countries
involved
20 000 +
investigational
Centres
3 million +
patients
in database
50 000 +
users
worlwide
LATEST NEWSOUR NEWS >
April 29, 2025
May 5 & 6 – Basel Telemedicine Technologies is pleased to present its CleanWeb™ eClinical suite, offering flexible, regulatory-compliant solutions tailored to every phase of clinical trials. Our platform includes a wide range of modules, such as eCRF, Randomization & Trial Supply Management, ePRO, eTMF, eConsent, Data Visualization, Vigilance, Imaging, CTMS, and more. We invite […]
April 29, 2025
Fierce Biotech The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. The data come from 20 pharmas that had the highest R&D budgets in 2020, as reported in Deloitte’s annual report, “Measuring the return from pharmaceutical innovation.” In 2024, the average […]
April 29, 2025
Biopharm International In January 2025, Samsung Biologics signed a six-year, $1.4 billion contract manufacturing agreement with an as-yet undisclosed European pharmaceutical company, with production to take place at Samsung’s manufacturing site in Songdo, South Korea (1). Simultaneously, at the J.P. Morgan Healthcare Conference held in San Francisco, the company announced plans to complete construction of […]